Home › News › Clinical Trials › Archive

Clinical Trial News Archive

Get news By email or subscribe to our News feeds.

All News Consumer Pharma New Drugs Pipeline Clinical Trials

May 2008

May 2

BioLineRx Presents BL-1020 Phase 2a Data at Society of Biological Psychiatry 63rd Annual Scientific Convention & Meeting Celgene Cellular Therapeutics Announces Clinical Transplant of Human Placenta-Derived Stem Cells Increases in West Nile Virus Replikin Concentrations Precede Increases in the Number of Human Cases Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting Somaxon Pharmaceuticals Announces Data to Be Presented at American Psychiatric Association 161st Annual Meeting IRX Therapeutics to Present Phase 2b Results at 3rd European Conference on Head & Neck Oncology Asphelia to Present At Digestive Disease Week 2008 in San Diego Four Out of Five High Blood Pressure Related Deaths Occur in Developing World More Than a Quarter of Americans Experience Pain

May 5

BioDelivery Sciences Presenting Phase III Data on BEMA Fentanyl at American Pain Society Meeting Anti-HIV NanoViricide Drug Candidate Demonstrates Significant Therapeutic Efficacy in Animal Trials Anesiva Announces Publication of Phase 3 Zingo Data in the Journal Pediatrics QLT completes enrollment in the RADICAL study YM Biosciences Announces Presentations for Aerolef at American Pain Society Annual Meeting Phase 3 Data Regarding Anti-RSV Antibody To Be Presented at Pediatric Academic Societies (PAS) Annual Meeting Results Published in JACC Show Clinical Advantage of Switching to Angiomax from Heparin in Acute Coronary Syndrome Patients Undergoing Early Invasive Treatment Senetek PLC Announces Positive Results from Pyratine-6(TM) Clinical Trial in Patients with Acne Rosacea N30 Pharma Announces Completion of Phase 1 Clinical Studies With N30-201 Can-Fite Successfully Completed Phase I Clinical Trial with its 2nd Drug CF102 Efficacy of FluMist in Children Highlighted at Pediatric Academic Societies Meeting Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants A Safer Alternative to Aspirin? Kidney Disease Substantially Worsens in a Fourth of African Americans Despite Therapy for Hypertension Unique Three-Year Data Demonstrating Long-Term Efficacy and Safety of Raptiva in the Treatment of Psoriasis Published in the British Journal of Dermatology QRxPharma Releases Successful Phase 3 Study Results for 'Dual Opioid' Pain Therapy Divigel (estradiol gel) 0.1 Percent Offers Lowest Approved Dose of Estradiol for Treatment of Moderate to Severe Hot Flashes Associated with Menopause Clinical Data Demonstrates 5-Year Efficacy and Safety of Aquamid in Facial Augmentation New Data on Seroquel XR in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting

May 6

Treprostinil Data to be Presented at Annual Meeting of the American Thoracic Society Affitech Announces Achievement of Significant Milestone in Antibody Discovery Collaboration NicOx announces U.S. phase 2a results for PF-03187207 and gives an update on continuing NO-prostaglandin program Novartis Menveo Vaccine Shows Superior Immune Response Against Four Types of Meningitis Disease in Pivotal Phase III Trial Two Year Study Confirms Supprelin LA Implant Maintains Profound Suppression of Hormones in Children With Premature Onset Puberty YM Biosciences Announces Schedule of Nimotuzumab Presentations at ASCO 2008 Annual Meeting New Data Show High Frequency of Medical Claims for Gastrointestinal Events by Patients on Antiplatelet Therapy New Study Confirms Dose-Accuracy of SoloSTAR Prefilled Insulin Pen Early Study Results Show New Stem Cell Treatment Successfully Treats Critical Limb Ischemia (CLI) Patients Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study Clinical Data, Inc. Presents Vilazodone Data at 2008 Annual Meeting of the APA Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events

May 7

Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources LifeCycle Pharma Announces Positive Data from LCP-AtorFen Phase II Clinical Program Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer ACE-011 Preclinical Data Published in the Proceedings of the National Academy of Sciences NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting The Nation's Leading Plastic Surgeons Learn about ArteFill's Five Year Safety and Long-Term Efficacy Data Steroids Provide No Survival Benefit for Children With Bacterial Meningitis Seven Clinical Presentations on Tapentadol Immediate Release for Acute Pain to Be Featured at 2008 American Pain Society Annual Meeting XTENT Announces Clinical Trial Data to be Presented at Annual EuroPCR Meeting Next Week Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Society's Annual Meeting New data demonstrate that risperidone long-acting injection extends time to relapse in patients with schizophrenia compared to those treated with oral quetiapine Abbott Scientists Present a New Approach for Treating Attention-Deficit Hyperactivity Disorder Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease New Analysis in Boys and Girls Shows the ADHD Patch, Daytrana (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months Shire's Investigational Nonstimulant ADHD Treatment Intuniv (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose Study Demonstrates Lexapro Significantly Improves Depression Symptoms in Adolescents iGuard.org Presents New Data on Statins at FDA Workshop Demonstrating How Patient-Reported Information Can Enhance Drug Safety Knowledge Clinical Data on Somaxon Pharmaceuticals' Product Candidate for the Treatment of Insomnia Presented at American Psychiatric Association Annual Meeting Savient Reports Favorable Interim Data from Puricase (pegloticase) Open Label Extension Study

May 8

Discovery Labs Presents Surfaxin Data At Pediatric Academic Societies Annual Meeting KeyNeurotek Pharmaceuticals Reports Positive Phase I Data of Its Cannabinoid Receptor-Agonist Anacor to Present Clinical and Preclinical Data on Topical Anti-Inflammatory Candidates, AN2728 and AN2898, at the International Investigative Dermatology 2008 Conference Array BioPharma Presents Additional Positive Phase 2 Results in Inflammatory Pain Clinical Trial at the American Pain Society's Annual Scientific Meeting New Abbott Study of Investigational Vicodin CR Meets Primary Efficacy Endpoints in Phase III Trial New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain Discovery Labs KL-4 Surfactant Technology Displays Antimicrobial Properties and Does Not Induce Immune Response in Preclinical Models BEMA(TM) Fentanyl Phase III Data Demonstrating Efficacy and Tolerability to be Presented at American Pain Society Annual Meeting GATTEX Abstracts Accepted for Presentation at DDW Conference; Phase 3 Short Bowel Syndrome Results Scheduled for Oral Plenary Session Aethlon Medical Releases Smallpox Related Research Data Data Show FLECTOR Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions Next Pharmaceuticals Announces a New Clinical Study Demonstrating Relora Significantly Relieves Short-Term Anxiety in Healthy Women Results of the Phase III Pivotal Study of Vyvanse (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists Collegium Pharmaceutical Inc. Presents Clinical Data for DETERx Abuse-Deterrent Sustained Release Technology at American Pain Society Meeting Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting BioDelivery Sciences Presents Phase III BEMA Fentanyl Data Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session

May 12

Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial Lunesta Study of Patients with Insomnia and Co-Morbid Generalized Anxiety Disorder (GAD) Published in Archives of General Psychiatry Affymax and Takeda Announce Long-Term Hematide Safety and Effectiveness Data from Phase 2 Clinical Trials in Chronic Kidney Disease Patients with Anemia New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery Starpharma Holdings Limited Reports Positive VivaGel Clinical Study Results Tengion to Present Preclinical Data For Regeneration of Entire Bladder Bone Medical further positive results from oral osteoporosis drug trial Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile NovaBay's Lead Aganocide Compound, NVC-422, Well Tolerated in the Bladder in Phase I Trial Novelos Therapeutics Announces Positive Results in Ongoing Phase 2 Neoadjuvant Breast Cancer Trial at MUSC Hollings Cancer Center Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury Repros Therapeutics Inc. Announces That Proellex Shows No Adverse Cardiac Effects In A Pilot Trial Nektar's PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress

May 13

Ardana Announces a Preliminary Evaluation of Its Testosterone Cream Pivotal Study and Provides an Update on Various Strategic Options AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal Valeant Announces Successful Completion of Retigabine Phase III Epilepsy Program Validating Novel Mechanism of Action XIENCE V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years ENDEAVOR II Four-Year Results Demonstrate Long-Term Safety and Durable Efficacy of Medtronic Drug-Eluting Stent Gene Therapy Slows Progression of Fatal Neurodegenerative Disease in Children Peregrine Pharmaceuticals Reports Studies Published in 'Science' Highlight Key Role of Phosphatidylserine (PS) in Viral Infections SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS and TAXUS Express Stents XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting Novel Treatment Offers Insomnia Sufferers Hope of Quality Sleep TAXUS Express Stent Shows Similarly Low Re-Intervention Rates in Patients with Diabetes Compared to Non-Diabetics in ARRIVE Registry Program

May 14

Kosan Announces Data Presentations at ASCO 2008 Annual Meeting Significant Blood Pressure Reductions Seen in Difficult-to-Treat, Black Patients Receiving Exforge-based Therapy In a Phase II Study, Novartis Meningitis B Vaccine Has Potential to Produce a Protective Immune Response in Infants, the Age Group Most at Risk Kosan Announces Data Presentations at ASCO 2008 Annual Meeting Cervarix Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date Lipid Sciences' Atherosclerosis Regression Data Presented at EuroPCR 2008 Congress New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with Benicar and Benicar HCT PRoFESS Results Announced at XVII European Stroke Conference Regenerative Medicine Offers Hope in Spinal Cord Injury Regado Biosciences' REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and Haemostasis Ambrilia Biopharma Announces Positive Phase III Results - Octreotide C2L

May 15

IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial Allos Therapeutics Reports Interim Response and Safety Data from Pivotal Phase 2 PROPEL Trial Avelox Monotherapy Shows Strong Performance in Treating Hospitalized Pneumonia Patients Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at Digestive Disease Week 2008 New data show Tekturna HCT is twice as effective at reducing blood pressure than the diuretic HCT alone Adherex Announces Publication of ADH-1 Study in Cancer Research Oculus Innovative Sciences to Participate in Third Congress of the World Union of Wound Healing Societies in Toronto New Hypertension Data Coming Out Of The American Society of Hypertension Annual Meeting From Daiichi Sankyo Cerenis Therapeutics Announces Successful Completion of Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease Tioga Pharmaceuticals to Present Asimadoline Phase 2b Data in Irritable Bowel Syndrome at Digestive Disease Week 2008 Annual Meeting New Data on Bristol-Myers Squibb Oncology Compounds to Be Featured in More Than 100 Abstracts at ASCO 2008 CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting Novel Microparticle Offers Immunological Breakthrough Against a Range of Infectious Diseases and Potentially Some Cancers Women Underestimate Their Risk of Spinal Fractures from Osteoporosis, Reveals a Spine-health.com Study Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke Independent Clinical Investigators to Present Data on Nymox BPH Drug at American Urological Association Meeting in Chicago September 25 Depth of MedImmune's Respiratory Disease Research Program Highlighted at Annual Meeting of the American Thoracic Society International Endeavor Registry Reports Safety and Performance of Medtronic Drug-Eluting Stent in Diverse Patient Population Landmark ATHENA Study Findings With Multaq (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation Azor Reduces Blood Pressure in Difficult to Treat Special Populations Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress Researchers Report Thymosin B4 Promotes Spinal Cord Nerve Cell Survival and Neurite Outgrowth

May 16

Dynavax TOLAMBA Chamber Study Misses Primary Endpoint; Company Updates 2008 Financial Outlook ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study Callisto Pharmaceuticals Reports Promising Interim Phase II Data for Atiprimod in Advanced Carcinoid Cancer Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study Medarex Announces June 2nd Webcast Review and Discussion of Ipilimumab Data Presented at ASCO 75 Abstracts Evaluating Celgene Products to Be Presented at The 44th American Society of Clinical Oncology Meeting Molecular Insight Pharmaceuticals, Inc. To Present Interim Phase 1 Data at ASCO on Azedra in Malignant Pheochromocytoma/Paraganglioma Patients Oncolytics Biotech Inc. Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients OncoGenex reports updated survival data on OGX-011 in a second-line chemotherapy trial for patients with prostate cancer The GI Company Reports Significant Reduction in Occurrence of Oral Mucositis in Phase II Study; Abstract Posted Online at ASCO.org GSK Announces Results of First Phase III Trial Evaluating Tykerb/Tyverb (lapatinib) Plus Herceptin (trastuzumab) ARIAD to Present Clinical Data at ASCO on the Anti-Tumor and Safety Profile of Its Oral Investigational mTOR Inhibitor, Deforolimus Genentech Provides Update on Studies of Investigational Biooncology Agents to Be Presented at the American Society of Clinical Oncology Meeting New Data Highlighting the Potential Utility of ABRAXANE in Combination with Targeted Therapies and Other Chemotherapeutic Agents to Be Presented at ASCO Nexavar Significantly Extends Overall Survival in Liver Cancer by 47 percent Dynavax to Discuss TOLAMBA Chamber Data; Update 2008 Outlook in Webcast This Morning MolMed to present Phase II trial preliminary results for its anticancer therapeutic Arenegyr at ASCO Annual Meeting 2008 New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings Renhuang Pharmaceuticals, Inc. Co-Sponsors Sino-German Workshop on Sleep Research Seattle Genetics Announces Upcoming SGN-35 Presentation at the American Society of Clinical Oncology Annual Meeting Erbitux (cetuximab) Data Demonstrate Improvements in Response Rate and Progression-Free Survival in Wild Type K-Ras Metastatic Colorectal Cancer Patients in First-Line Setting Significant Data on Erbitux (cetuximab) and ImClone Pipeline to Be Presented at American Society of Clinical Oncology 2008 Annual Meeting Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008 New Pfizer Data in Lung Cancer, Ewing's Sarcoma, Prostate Cancer and Other Difficult-to-Treat Tumor Types to Be Presented at ASCO Amgen Highlights Data to Be Presented at ASCO Genentech Provides Update on Avastin Program Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting IDM Pharma Announces Presentations at 44th American Society of Clinical Oncology Annual Meeting Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes CLSI Publishes Updated Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi Iressa Shows Promise For Treatment of Metastatic Breast Cancer When Combined With Hormonal Therapy Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day New Drug Combination Brings One-Two Punch Against Acute Leukemia New Data Support High Complete Remission Rates With Velcade (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma

May 19

NovaBay (NBY) Announces Positive Results From Phase IIA Study of AgaNase For Nasal Decolonization of Staph including MRSA Spectrum Pharmaceuticals to Present Phase 2 Data on Ortataxel in Breast Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting NanoViricides' EKC Eye Drug Demonstrates Significant Therapeutic Efficacy in Initial Animal Trials RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients with Advanced Kidney Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting Phenomix Announces PHX1149 Phase 2b Clinical Trial Results for Type 2 Diabetes Advair Reduces Exacerbations in COPD Patients With a History of Exacerbations Additional Digestive Disease Week Data Highlight Effects of Amitiza in patients with IBS-C RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients with Advanced Kidney Cancer Positive Clinical Data with Santarus' Zegerid Capsules in Controlling 24-Hour Gastric Acidity Presented in DDW Abstract Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis Highest Replikin Concentrations and Cyclical Behavior Related to Human Mortality Are Found in Malaria Trypanosomes Adherex Announces ASCO Abstract of ADH-1 in Melanoma Researchers Report Thymosin B4 Protects Human Cornea Epithelial Cells Against Oxidative Damage Pozen Announces PN 200 Podium Presentation at Digestive Disease Week Study Identifies Novel Glycan Markers, Anti-L & Anti-C, That Predict Aggressive Crohn's Disease and Improve Differentiation Between Crohn's Disease and Ulcerative Colitis Argos Therapeutics Discusses Novel Solutions for Automated Immunotherapy Manufacturing at ISCT Annual Meeting Ark Makes Significant Advances with EG013 and EG014 Preclinical Programmes Pegasys/Copegus Show Benefit in Hard-to-Treat Latino Population with Hepatitis C Infant Primates Given Vaccines on U.S. Children's Immunization Schedule Develop Biomedical and Behavioral Symptoms of Autism ASCO Selects 28 Sarah Cannon Studies for Presentation at Annual Meeting ASCO 2008: Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Metastatic Pancreatic Cancer RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer Transgene Announces Promising Phase I Preliminary Results of Its HCV Therapeutic Vaccine ASCO 2008: Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity without Toxicity in Metastatic Pancreatic Cancer Phase 3 Gattex Results Presented at Annual Digestive Disease Week Congress Highlight Potential New Treatment in Short Bowel Syndrome VioQuest Pharmaceuticals Announces Upcoming Lenocta Oral Presentation at the American Society of Clinical Oncology Annual Meeting Gloucester Pharmaceuticals Announces Positive Results from Phase 2b Registration Trial of Romidepsin in Refractory CTCL Amikacin Inhale Shows Promising Results in Phase II Study

May 20

Data Show Rufinamide, an Investigational Adjunctive Treatment for Lennox- Gastaut Syndrome, Reduced Drop Attacks by More Than 40% Compugen Presents Experimental Results for Three G-Protein Coupled Receptor (GPCR) Ligands KAI Pharmaceuticals Advances Third Product Candidate into Clinical Studies Denosumab Osteoporosis Study Meets Primary and All Secondary Bone Mineral Density Endpoints in Alendronate (FOSAMAX(R)) Transition Study Halozyme Therapeutics Presents Pre-Clinical Studies on Dermal Remodeling With HTI-501, a Lysosomal Proteinase Protox to present BPH data at AUA Conference ImmuPharma’s Cancer Drug Candidate IPP- 204106 Shows Complete Response to Tumours in Multiple Human Cancer Cell Lines Medication May Prevent Depression in Patients with Head and Neck Cancer Delayed Adverse Effects May Occur Following Injection with Cosmetic Skin Fillers Enzon Announces Clinical Data from PEG-SN38 and rhMBL Studies at ASCO Dynogen Presents Results of Its Positive Phase 2 IBS-d Study with DDP225 Ceragenix Announces Results of a Comparison Study of the Safety and Efficacy of EpiCeram Cream for the Treatment of Mild to Moderate Pediatric Atopic Dermatitis Asthma Patients Not Adequately Controlled on ICS Alone More Likely to Benefit From Advair Than Doubling the Dose of ICS New Patient Satisfaction Study With budesonide/formoterol Combination Therapy and fluticasone/salmeterol Combination Therapy in Adults With Asthma Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-naïve Patients with Metastatic Melanoma Diasome Pharmaceuticals to Present at the 68th Annual American Diabetes Association Meeting Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma Therapeutic DNA Vaccine Company Inovio Biomedical to Present at Upcoming Scientific Conferences Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone Gilead Announces New Letairis (Ambrisentan) Data for the Treatment of Patients With Pulmonary Arterial Hypertension (WHO Group 1) With WHO Functional Class II or III Symptoms Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of Lialda (mesalamine) Presented at DDW New Analysis Shows Efficacy of Remicade in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease Balsalazide 3.3 Grams Twice-Daily Shows Significant Improvement in Bowel Function and Some Quality of Life Measures as Early as Week Two Dynogen Presents Results of Its Positive Phase 2a IBS-c Study with DDP733 Salix Presents New Rifaximin Phase IIb Data Demonstrating Significant and Sustained Improvement in Diarrhea-Associated Irritable Bowel Syndrome (D-IBS) Ceftobiprole shows high cure rates in patients hospitalized with community-acquired pneumonia Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD Study Analyzed Symbicort in Children with Persistent Asthma Newly-Approved Cimzia Provides Rapid, Sustained Response in Crohn's Patients

May 21

Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis Data from Phase IIb trial of Elocalcitol in BPH presented at the annual meeting of the American Urological Association Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology Medarex Reports Phase 1 Clinical Data of MDX-1100 at Digestive Disease Week Cell Genesys Reports Encouraging Interim Data From Phase 1 Clinical Trial of CG0070 in Recurrent Bladder Cancer Excellent clinical trial data from Photocure's photodynamic diagnostic Lumacan Alnylam and Collaborators Publish In Vivo Research on Validation of a Mammalian Host Gene Involved in Malaria Infection and on the Anti-Parasitic Efficacy of RNAi Therapeutics Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents ATHENA Clinical Results for Dronedarone (Multaq) Highlighted at the World Cardiology Congress QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder ImmunoCellular Therapeutics Announces Completion of Proof-of-Principle Studies Demonstrating Efficacy of Cancer Stem Cell Vaccine in Preclinical Model Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference Sanofi-aventis and Regeneron Update Aflibercept (VEGF Trap) Clinical Development Program in Oncology Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With Humira (Adalimumab) Maintained Remission Three-Year COPD Study Found No Increase in Cardiac Events With Advair 500/50 Plexxikon Announces Preclinical Data Demonstrating Dramatic Improvement in Key Symptoms of Polycystic Kidney Disease

May 22

Wyeth and Progenics Announce Preliminary Clinical Trial Results for Relistor Oral and Intravenous Formulations AVANT Immunotherapeutics Announces Oral Presentation of CDX-110 at ASCO Annual Meeting Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration New Analysis Showed That High Dose Lipitor Can Reduce the Risk of Cardiovascular Events in Bypass Surgery Patients Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program Cougar Biotechnology to Present Clinical Data on CB7630 (Abiraterone Acetate) at American Society of Clinical Oncology 2008 Annual Meeting Caphosol Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation Opexa Therapeutics Presents Myelin Reactive T-Cell Research at the International Society of Cell Therapy Annual Meeting Results Published in New England Journal of Medicine Show Angiomax Improved Net Clinical Outcomes and Resulted in Improved Survival Rates in the Most Severe Heart Attack Patients QRxPharma Releases Additional Phase 3 Data for Q8003IR 'Dual Opioid' Pain Therapy Nearly 60 New Studies of Oral Xeloda (capecitabine) Featured at the 44th American Society of Clinical Oncology Annual Meeting Stabilizing Cancer-Fighting p53 Can Also Shield a Metastasis-Promoter Anti-rejection Drug May Increase Risk of Diabetes After Kidney Transplant Rexin-G Monotherapy Reveals Significant Biological Activity without Toxicity in Chemo-Resistant Metastatic Breast Cancer Tioga Pharmaceuticals’ Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome Micromet to Present Clinical Update for BiTE Antibody MT103/MEDI-538 at the International Conference on Malignant Lymphomas

May 27

Favrille Announces Results from Phase 3 Registration Trial of Specifid in Patients with Follicular B-Cell Non-Hodgkin's Lymphoma Osteologix Presents Phase 2 Osteoporosis Data at a Major European Medical Conference Isotechnika reports final results of the PROMISE trial ImmunoGen, Inc. Announces Presentations at Upcoming 2008 American Society of Clinical Oncology Annual Meeting Odanacatib, Merck's Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases AVANIR Announces Positive Outcome of Zenvia PK Study Neose Announces Two Abstracts on GlycoPEGylated Factor VIIa Accepted for Presentation at the Hemophilia 2008 World Congress ThromboGenics Presents Further Results of the Vitreomacular Traction Trial (MIVI IIT) at the Euretina Annual Meeting in Vienna Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting BMJ: Oral HRT More Than Doubles the Risk of Blood Clots OSI Pharmaceuticals to Provide a Summary of Data Presented at the 2008 American Society of Clinical Oncology Meeting Node-negative early stage breast cancer patients benefit from Taxotere-based chemotherapy Brainstorm Cell Therapeutics Chief Scientist, Dr. Daniel Offen, To Present Results from New Parkinson's Study at International Stem Cell Meeting in Tel Aviv Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere-Based Chemotherapy Innate Pharma Announces Phase Iia Results with IPH 1101 as Second Line Monotherapy in Metastatic Renal Cell Carcinoma Synairgen present data regarding barrier function-improving peptide at ATS TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008) Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions

May 28

NanoViricides in Discussions with Pharma about EKC Eye Drug Candidate Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives Study Showed Alimta (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer Elixir Pharmaceuticals Researchers Publish New Data Validating Ghrelin as a Key Metabolic Regulator Amgen Announces Webcast to Discuss Results of Denosumab Phase 3 Head-to-Head Study Versus Alendronate at the Upcoming European Symposium on Calcified Tissues Conference Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress Santhera Presents Efficacy Data of SNT-317 in Congenital Muscular Dystrophy at International Congress of Myology Oculus Innovative Sciences Announces Publication of Microcyn Technology Post-Caesarean Section Wound Study in Indian Medical Gazette Phase III Clinical Study Using BSD Medical's Systems for Treating Pancreatic Cancer to Be Announced at ASCO Denosumab Achieved Superior Bone Mineral Density Gains in Head-to-Head Trial versus Weekly Alendronate (Fosamax) GPC Biotech Announces Data from Several Satraplatin Clinical Trials to be Presented at ASCO Annual Meeting Astex Drug Candidates to be Presented at the 2008 American Society of Clinical Oncology Annual Meeting Advexin Improves Survival in Recurrent, Refractory Head and Neck Cancer Patients ImmunoCellular Therapeutics Announces Ability to Characterize Distinct Antigens Between Cancers Using Monoclonal Antibody Technology Access Pharmaceuticals Presents New Data on the Company's Cobalamin Technology at an International Polymer Therapeutics Symposium Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac Development at Prestigious International Symposium Nymox Reports Significant Long-Term Improvement in BPH Symptoms After NX-1207 Treatment in New Multi-Center U.S. Study Gene Therapy Increases Survival for End-Stage Head and Neck Cancer

May 29

Reduction of Pain, Itching, and Rash Shown in Study of Oncology Patients by MPM Medical, Inc., Subsidiary of RBC Life Sciences Novadaq Updates on Optix Data Reported at Euroretina Repros Therapeutics Inc. Announces That Initial Findings for Proellex Show No Adverse Effects on the Endometrium after One Year on Drug EpiCept Announces Presentation of EPC2407 Data at 2008 American Society of Clinical Oncology Annual Meeting Alfacell Corporation Announces Preliminary Results From Onconase Phase IIIb Clinical Trial BrainStorm Cell Therapeutics NTF Cells Shows Significant Advantage in Pre-Clinical Study for Parkinson's Disease Arenegyr: Key Preliminary Results of Phase II Trials in Mesothelioma and Colorectal Cancer Presented at ASCO Long-Term Followup in Phase 3 CLL Trial Shows Genasense is Associated with Significantly Increased Survival in All Responders Strativa Pharmaceuticals Announces Preliminary Results from Onconase Phase IIIb Clinical Trial EpiCept Announces Presentation of EPC2407 Data at 2008 American Society of Clinical Oncology Annual Meeting GenVec Presents Encouraging Data on TNFerade in Esophageal Cancer New England Journal of Medicine Publishes Results From a Relistor Phase 3 Clinical Study Data from Pivotal Phase III Studies of Gilead's Letairis (ambrisentan) for Pulmonary Arterial Hypertension (WHO Group 1) in Patients with WHO Functional Class II or III Symptoms Published in Circulation Cleviprex(TM) Reduces and Controls Acutely Elevated Blood Pressure in Elderly Patients, According to New Analysis from VELOCITY Trial Introgen Presents Top Line Data from Phase III Advexin Clinical Trial Salix Presents New Rifaximin Phase IIb Data Demonstrating Significant And Sustained Improvement in Diarrhea-Associated Irritable Bowel Syndrome (d-IBS) Cellceutix Cancer Compound: Crunching the Numbers Advexin Improves Survival in Recurrent, Refractory Head and Neck Cancer Patients Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients LifeCycle Pharma to Present Data at American Transplant Congress (ATC) in Toronto Graceway Pharmaceuticals Reports Study in Journal of Pediatrics: Atoplclair is Effective Monotherapy for Mild to Moderate Atopic Dermatitis in Infants and Children Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients With Progressive Chemo-Resistant Bone and Soft Tissue Sarcoma (ASCO 2008)

May 30

Rivaroxaban Superior to U.S.-Approved Dosing Regimen for Enoxaparin in Reducing Venous Blood Clots after Total Knee Replacement Surgery in Pivotal Phase III Trial PTC124 Featured at Third Annual Congress of Myology NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia, Bipolar Disorder and Depression Phase III Data on BEMA Fentanyl to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting Presentation of Data on Progen's Cancer Epigenetic Targets Platform AMT Announces Positive Interim Clinical Data on its Lead Product AMT-011 Two Doxil Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting Participants in TCA Cellular Therapy's Stem Cell Protocol Experiencing Remarkable Results Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at ASGT Meeting Data from Clinical Trial of MediGene's EndoTAGTM-1 in the Indication Pancreatic Cancer Will be Presented at ASCO Annual Meeting Antisoma Announces Positive ASA404 Presentations at ASCO Vion Pharmaceuticals to Present Clinical Data on Cloretazine (VNP40101M) at the ASCO Annual Meeting Continuing Herceptin Treatment Prevents Disease Progression in Women with Aggressive Metastatic Breast Medarex Hosts June 2nd Webcast of Ipilimumab Data Presented at ASCO AmpliMed Corporation to Present Clinical Data from Three Clinical Trials of Amplimexon at American Society of Clinical Oncology Annual Meeting Genasense Chemotherapy Program Yields High Response Rate in Patients with Stage 4 Melanoma Data from Clinical Trial of MediGene's EndoTAGTM-1 in the Indication Pancreatic Cancer will be presented at ASCO Annual Meeting Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma Medarex Hosts June 2nd Webcast of Ipilimumab Data Presented at ASCO Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan) VIRxSYS Presents New VRX496 Phase II HIV Gene Therapy Trial Data Argos Therapeutics Presents Data on the Mechanism of Immunosuppression by Soluble CD83 at the American Transplant Congress Clavis Pharma ASA To Present Phase I Clinical Results from Elacyt In Patients with Cancers of the Blood Side Effects of Sunitinib in Kidney Cancer are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon Immunicon Corporation to Present at 2008 ASCO Annual Meeting Nymox Announces New Clinical Trial Data Presentation on BPH Drug at Upcoming American Urological Association Meeting Welchol Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated Pfizer Oncology ASCO 2008 Media Briefing to Discuss Study Results in Broad Range of Cancers Spontaneous Mutations Rife in Non-familial Schizophrenia About 60 Clinical Studies Regarding Schering-Plough's Oncology Compounds Will be Presented at ASCO BioAlliance Pharma Presents New Results on its AMEP Anti-invasive Biotherapy

Clinical Trial Results Archive

2005

April

More News Resources

(web3)